SSY Group Limited (SEHK: 2005)
Health Care · Pharmaceuticals · HK
HK$2.48
+2.91% today · -20.2% 1Y
SSY Group Limited (SEHK: 2005) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $912.79M and employs 5,472 people.
Over the last twelve months the share price has lost 20.2%, trading between 2.01 and 3.40.
Tweenvest scores SSY Group Limited across four factors: quality 66/100, value 51/100, growth 15/100, dividend 90/100. Its strongest factor is dividend.
2005 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $912.79M
- Revenue (TTM)
- $535.17M
- P/E
- 15.42
- EPS
- 0.16
- Dividend yield
- 3.23%
- Beta (5Y)
- 0.52
- 52-week high
- HK$3.40
- 52-week low
- HK$2.01
- Avg volume (3M)
- —
- Shares outstanding
- 2.89B
- Employees
- 5,472
- Next earnings
- —
About SSY Group Limited
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
- ISIN
- KYG8406X1034
- Founded
- 1999
- Listed since
- Dec 20, 2005
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.